# Brii BioSciences

**Canonical:** https://apis.io/providers/brii-biosciences/  
**Website:** https://www.briibio.com  
**APIs profiled:** 0

Brii BioSciences Limited (stock code: 2137.HK) is a biotechnology company founded in 2018, developing therapies for high unmet medical needs, notably hepatitis B virus infection. Operating in China and the United States, the firm focuses on innovative therapeutic candidates and has a pipeline of unique programs. It employs a visionary leadership team and aims to improve patient health through advanced biotech research.

## Kin Score — 8.6 / 100 (minimal)

Scored 2026-10-09 under rubric 0.23.0.

| Facet | Score |
|---|---|
| Discoverability | 46.4 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 21.1 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 13.7 (matched via fallback).

## Agent readiness — 3.1 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | documented |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Brii Biosciences Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Biotech, Monoclonal Antibodies, Infectious Diseases, Hepatitis B, COVID-19, Neuroscience, China

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/brii-biosciences/). Scores are computed from the provider's own public artifacts under a published rubric.